These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 31658707)

  • 21. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
    Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
    Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
    J Virol; 2017 May; 91(10):. PubMed ID: 28298600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.
    da Silva-Júnior EF; de Araújo-Júnior JX
    Bioorg Med Chem; 2019 Sep; 27(18):3963-3978. PubMed ID: 31351847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic peptide optimization improves the inhibition of dengue NS2B-NS3 protease and dengue replication in vitro.
    Abdulrahman AY; Rothan HA; Khazali AS; Teoh TC; Daher AM; Yusof R
    Acta Virol; 2019; 63(3):278-285. PubMed ID: 31507193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism through Which Retrocyclin Targets Flavivirus Multiplication.
    Jia X; Guo J; Yuan W; Sun L; Liu Y; Zhou M; Xiao G; Lu W; Garzino-Demo A; Wang W
    J Virol; 2021 Jul; 95(15):e0056021. PubMed ID: 33980602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
    Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
    Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor.
    Chan JF; Chik KK; Yuan S; Yip CC; Zhu Z; Tee KM; Tsang JO; Chan CC; Poon VK; Lu G; Zhang AJ; Lai KK; Chan KH; Kao RY; Yuen KY
    Antiviral Res; 2017 May; 141():29-37. PubMed ID: 28185815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.
    Wahaab A; Mustafa BE; Hameed M; Stevenson NJ; Anwar MN; Liu K; Wei J; Qiu Y; Ma Z
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
    Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
    Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A small molecule inhibitor of ER-to-cytosol protein dislocation exhibits anti-dengue and anti-Zika virus activity.
    Ruan J; Rothan HA; Zhong Y; Yan W; Henderson MJ; Chen F; Fang S
    Sci Rep; 2019 Jul; 9(1):10901. PubMed ID: 31358863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease.
    Nie S; Zhao J; Wu X; Yao Y; Wu F; Lin YL; Li X; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y
    Eur J Med Chem; 2021 Dec; 225():113767. PubMed ID: 34450494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease.
    Saqallah FG; Abbas MA; Wahab HA
    Phytochemistry; 2022 Oct; 202():113362. PubMed ID: 35948138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
    Velmurugan D; Mythily U; Rao K
    Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flavonoids from Pterogyne nitens as Zika virus NS2B-NS3 protease inhibitors.
    Lima CS; Mottin M; de Assis LR; Mesquita NCMR; Sousa BKP; Coimbra LD; Santos KB; Zorn KM; Guido RVC; Ekins S; Marques RE; Proença-Modena JL; Oliva G; Andrade CH; Regasini LO
    Bioorg Chem; 2021 Apr; 109():104719. PubMed ID: 33636437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation.
    Panayiotou C; Lindqvist R; Kurhade C; Vonderstein K; Pasto J; Edlund K; Upadhyay AS; Överby AK
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxycycline Interferes with Zika Virus Serine Protease and Inhibits Virus Replication in Human Skin Fibroblasts.
    Chong Teoh T; J Al-Harbi S; Abdulrahman AY; Rothan HA
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.
    Mirza MU; Alanko I; Vanmeert M; Muzzarelli KM; Salo-Ahen OMH; Abdullah I; Kovari IA; Claes S; De Jonghe S; Schols D; Schinazi RF; Kovari LC; Trant JF; Ahmad S; Froeyen M
    Eur J Pharm Sci; 2022 Aug; 175():106220. PubMed ID: 35618201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
    Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
    Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
    Loe MWC; Lee RCH; Chu JJH
    Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.